EU for Evibodies
By Kate McDonald
Monday, 09 February, 2009
Monday, 09 February, 2009
Arana Therapeutics has been granted an EU patent for its Evibodies range of small antibodies.
Evibodies were part of the technology platform brought into the company by EvoGenix when it merged with Peptech in 2007.
Evibodies are small fragments of a family of proteins that act like antibodies but are about one-tenth smaller.
They were given a US patent in 2007.
Related News
Newborns have elevated levels of an Alzheimer's biomarker
What do the brains of newborns and patients with Alzheimer's disease have in common? Both...
Cannabis use may double risk of cardiovascular disease death
Cannabis users have a 29% higher risk of acute coronary syndrome, a 20% higher risk of stroke,...
Space conditions can lead to periodontitis, scientists say
Living in zero gravity can lead to periodontitis — a serious condition where the gums...
